1. Tatematsu M, Kawamoto T, Hayashida K, Yoshioka H, Wada T, Ueyama K, Nakajima Y, Nagano Y, Takechi H, Tanaka M, Horiuchi H, Ishii K, Arai H, Kume N, Wakatsuki Y, Murakami M, Matsubayashi K, Kita T, Yokode M: Pre-operative assessment scale for the elderly Japanese patients (part I)Its basic study design and clinical trial. Geriatr. Gerontol. Int.2: 36-39.
  2. Watanabe T, Yoshida M, Shirai Y, Yamori M, Yagita H, Itoh T, Chiba T, Kita T. and Wakatsuki Y: Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver1. J. Immunol. Vol. 168: 2188-2199.
  3. Hayashida K, Kume N, Minami M, Kita T: Lectin-like oxidized LDL receptor-1 (LOX-1)support adhesion of mononuclear leukocytes and a monocyte-like cell line THP-1 cells under static and flow conditions. FEBS Lett. Vol. 511: 170-174.
  4. Ho H. K, Matsubayashi K, Lim F. S, Sahadevan S, Kita T, Saijoh K: Hypertension in Japanese old-old. Lancet 359: 804.
  5. Morimoto M, Kume N, Miyamoto S, Mizoguchi A, Nozaki K, Sadamasa N, Kita T, Hashimoto N: The roles of MMPs for cerebral aneurysm formation strategic medical science against brain attack? Springer pp.223-233.
  6. Kume N, Kita T: New Scavenger Receptors and their functions in atherogenesis.Current Atherosclerosis Reports 4: 253-257.
  7. Yanagita M, Ishimoto Y, Arai H, Nagai K, Ito T, Nakao T, Salant D.J, Fukatsu A, Doi T, Kita T: Essential role of gas6 for glomerular injury in nephrotoxic nephritis. J. Clin. Invest. 110: 239-246.
  8. Sano H, Ueda Y, Takakura N, Takemura G, Doi T, Kataoka H, Murayama T, Yang X, Sudo T, Nishikawa S, Nishikawa S-I, Fujiwara H, Kita T, Yokode M: Blockade of platelet-derived growth factor receptor-β pathway induces apoptosis of vascular endothelial cells and disrupts glomerular capillary formation in neonatal mice. Am. J. Pathol. 161: 135-143.
  9. Yokode M, Kita T: Aging and Oxidative Stress. Japan Med. Assoc. J. 45(7)277-282.
  10. Fujiwara Y, Watanabe S, Kumagai S, Yoshida Y, Takabayashi K, Morita M, Hasegawa A, Hoshi T, Yokode M, Kita T, Shinkai S: Prevalence and characteristics of older community residents with mild cognitive decline. Geriatr. Gerontol. Int. 2: 57-67.
  11. Ho H. K, Matsubayashi K, Wada T, Kimura M, Kita T, Saijoh K: Factors associated with ADL dependence: A comparative study of residential care. Home and community-dwelling elderly in Japan. Geriatr. Gerontol. Int. 2: 80-86.
  12. Tanaka M, Fukuyama H, Yamauchi H, Narita M, Nabatame H, Yokode M, Fujimoto N, Kita T, Murakami M: Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J. Neuroimaging.12(2):112-8.
  13. Fukuhara A, Irie K, Nakanishi H, Takekuni K, Kawakatsu T, Ikeda W, Yamada A, Katata T. Honda T, Sato T, Shimizu K. Ozaki H. Horiuchi H, Kita T. and Takai Y: Involvement of nectin in the localization of junctional of adhesion molecule at tight junctions. Oncogene 21: 7642-7655.
  14. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and the J-LIT Study Group: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. - Primary prevention cohort study of the Japan lipid intervention trial (J-LIT)-. Circulation J. 66: 1087-1095.
  15. Wada T, Matsubayashi K, Okumiya K, Saz E.G.D, Kita T: Health Status And Subjective Economic Papua. Lancet 360: 951.
  16. Funabiki Y, Takechi H, Akamatsu T, Kita T: Development of a short neuropsychological battery to screen early dementia in the Elderly. Geriatr. Gerontol. Int. 2: 179- 186.
  17. Fujiwara Y, Watanabe S, Kumagai S, Yoshida Y, Takabayashi K, Morita M, Hasegawa A, Hoshi T, Yokode M, Kita T, and Shinkai S: Prevalence and characteristics of older community residents with mild cognitive decline. Geriatr. Gerontol. Int. 2: 57- 67.
  18. Kume N and Kita T: Roles of oxidized low-density lipoprotein and its receptors in the pathogenesis of atherosclerotic diseases. Geriatr. Gerontol. Int. 2: 172- 178.
  19. Miura K, Nakagawa H, Morikawa Y, Sasayama S, Matsumori A, Hasegawa K, Ohno Y, Tamakoshi A, Kawamura T, Inaba Y. Epidemiology of idiopathic cardiomyopathy in Japan: Results from a nationwide survey. Heart 87(2)126-130
  20. Matsumori A, Takano H, Obata J, Takeda S, Tsuyuguchi N, Ono K, Okada M, Miyamoto T, Ohnishi T, Daikuhara Y, Sasayama S. Circulating hepatocyte growth factor as a diagnostic marker of thrombus formation in patients with cerebral infarction. Circulation J. 66(2)216-218
  21. Hara M, Ono K, Hwang MW, Iwasaki A, Okada M, Nakatani K, Sasayama S, Matsumori A. Evidence for a role of mast cells in the evolution to congestive heart failure. J. Exp. Med. 1195(3)375-381
  22. The EPOCH Study Group. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure- The effects of pimobendan on chronic heart failure study (EPOCH Study)Circulation J. 66(2)149-157
  23. Matsumori A, Furukawa Y, Hasegawa K, Sato Y, Nakagawa H, Morikawa Y, Miura K, Ohno Y, Tamakoshi A, Inaba Y, Sasayama S. Epidemiologic and clinical characteristics of cardiomyopathies in Japan -Results from nationwide surveys-. Circulation J. 66(4)323-336
  24. Adachi O, Nakano A, Sato O, Kawamoto S, Tahara H, Toyoda N, Tamamoto E, Matsumori A, Tabayashi K, Miyazaki J. Gene transfer of Fc-fusion cytokine by in vivo electroporation: application to gene therapy for viral myocarditis. Gene Therapy 9: 577-583
  25. Ono K, Matsumori A. Endothelin antagonism with bosentan: current status and future perspectives. Cardiovasc. Drug. Rev. 20(1)1-18
  26. Nakao T, Arai S, Kaido T, Mori A, Murata T, Matsumori A, Imamura M. Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels. J. Hepatol. 37(1)87-92
  27. Nishio R, Sasayama S, Matsumori A. Left ventricular pressure-Volume relationship in a murine model of congestive heart failure due to acute viral myocarditis. J. Am. Coll. Cardiol. 40(8)1506-1514
  28. Ito H, Ono K, Nishio R, Sasayama S, Matsumori A. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice. Cytokine 17(4)197-202
  29. Matsumori A. Chapter 5 Cytokines in experimental myocarditis. Myocarditis edited by Cooper. The Humana Press Inc. Totowa NJ, USA. pp109-133
  30. Kusano H, Ono T, Nogaki F, Nomura K, Takeda T, Miyawaki S, Matsumori A, Yoshida H, Sasayama S. Heminephrectomy causes the progression of glomerulosclerosis and apoptosis in high lgA strain ddY mice. Nephron. 92: 389-398
  31. Matsumori A. Cytokines in myocarditis and dilated cardiomyopathy. Europ. Heart J. 4 (suppl 1)142-145
  32. Kinoshita M, Miyamoto T, Ohashi N, Sasayama S, Matsumori A. Thrombosis increases circulatory hepatocyte growth factor by degranulation of mast cells. Circulation 106: 3133- 3138.
  33. Sato Y, Taniguchi R, Makiyama T, Nagai K, Okada H, Yamada T, Matsumori A, Takatsu Y: Measurements of serum cardiac troponin T and plasma brain natriuretic peptide in patients with severe cardiac decompensation. Heart (Scientific letter)88: 647-648.
  34. Furukawa Y, Libby P, Stinn JL, Becker G, Mitchell RN: Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy arteriopathy in non-immunosuppressed hosts. Am. J. Pathol. 160:1077-1087.
  35. Saito J, Niwano S. Niwano H, Inomata T, Yumoto Y, Ikeda K, Inuo K. Kojima J. Horie M, Izumi T: Electrical remodeling of the ventricular myocardium in myocarditis-studies in The Rat Experimental Autoimmune Myocarditis (EAM)Circulation J. 66: 97-103.
  36. Noda T, Takaki H, Kurita T, Suyama K, Nagaya N, Taguchi A, Aihara N, Kamakura S, Sunagawa K, Nakamura K, Ohe T, Horie M, Carlo Napolitano, Jeffrey A. Towbin, Silvia G. Priori, Shimizu W: Gene-Specific Response of Dynamic Ventricular Repolarization to Sympathetic Stimulation in LQT1, LQT2 and LQT3 Forms of Congenital Long QT Syndrome. Eur. Heart J. 23: 975-983
  37. Ai T, Ikeguti S, Watannuki M, Amaya N, Ninomiya T, Horie M, Kawai C: Successful RF current catheter of accessory atrioventricular pathway in Ebstein's anomaly using electroanatomical mapping. Pacing Clin. Electrophysiol.25: 374-375
  38. Kubota T, Horie M, Takano M, Yoshida H, Otani H, Sasayama S: Role of KCNQ1 in the cell swelling-induced enhancement of the slowly activating delayed rectifier K+ current Jpn. J. Physiol. 52: 31-39.
  39. Ai T, Fujiwara Y, Tsuji T, Otani H, Nakano S, Kubo Y, Horie M : KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. Circulation 105: 2592-2594
  40. Makita N, Horie M, Nakamura T, Ai T, Otani H, Sawa H, Kitabatake A: Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 106:1269-1974
  41. Haruna T, Yoshida H, Nakamura TY, Xie LH, Otani H, Ninomiya T, Takano M, Coetzee WA, Horie M. a1-Adrenoceptor-mediated breakdown of phosphatidylinositol 4,5-bisphosphate inhibits pinacidil-activated KATPcurrents in rat ventricular myocytes. Circ. Res. 91: 232-239
  42. Takimoto Y, Aoyama T, Iwanaga Y, Izumi T, Kihara Y, Pennica D, Sasayama S: Increased expression of cardiotrophin-1 and gp 130 during ventricular remodeling in hypertensive rats. Am. J. Physiol. 282: H896-H901.
  43. Miyamoto S, Nagaya N, Ikemoto M, Tambara K, Kihara Y, Onozawa Y, Hasegawa K, Yamazato A, Fujita M: Elevation of matrix metalloproteinase-2 level in pericardial fluid is closely associated with left ventricular remodeling. Am. J. Cardiol. 89: 102-105
  44. Iwanaga Y, Aoyama T, Kihara Y, Onozawa Y, Yoneda T, Sasayama S: Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats. J. Am. Coll. Cardiol.39: 1384-1391.
  45. Inagaki K, Iwanaga Y, Sarai N, Onozawa Y, Takenaka H, Mochly-Rosen D, Kihara Y: Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC varepsilon and PKCbeta. J. Mol. Cell Cardiol. 34:1377-1385.
  46. Sarai N, Kihara Y, Izumi T, Sasayama S, Mitsuiye T, Matsuoka S, Noma H: Nonuniformity of sarcomere shortenings in the isolated rat ventricular myocyte. Jap. J. Physiol. 52(4)371-381.
  47. Noguchi T, Kihara Y, Begin KJ, Gorga JA, Palmiter KA, LeWinter MM, VanBuren P: Altered myocardial thin-filament function in the failing Dahl salt-sensitive rat heart: amelioration by endothelin blockade. Circulation 107 (4)630-5.
  48. Iwai-Kanai E, Hasegawa K, Fujita M, Araki M, Yanazume T, Adachi S, Sasayama S: Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J. Cell Physiol. 190:54-62.
  49. Miura K, Nakagawa H, Morikawa Y, Sasayama S, Matsumori A, Hasegawa K, Ohno Y, Tamakoshi A, Kawamura T, Inaba Y: Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey. Heart 87:126-130.
  50. Miyamoto S, Tambara K, Tamaki S, Nagaya N, Hasegawa K, Nohara R, Miwa K, Fujita M: Effects of right lateral decubitus position on plasma norepinephrine and plasma atrial natriuretic peptide levels in patients with chronic congestive heart failure. Am. J. Cardiol. 89:240-242.
  51. Yanazume T, Hasegawa K, Wada H, Morimoto T, Abe M, Kawamura T, Sasayama S: Rho/ROCK pathway is required for the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy. J. Biol. Chem. 277:8618-8625.
  52. Wada H, Hasegawa K, Morimoto T, Kakita T, Yanazume T, Abe M, Sasayama S: Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J. Cell Biol. 156:983-991.
  53. Miyamoto S, Fujita M, Ueda K, Tamaki S, Hasegawa K, Nagaya N, Sasayama S: Shunt between the ventricular chamber and coronary arteries preserves left ventricular function in acute myocardial infarction. Circulation J. 66:633-638.
  54. Goto Y, Sumida H, Ueshima K, Adachi H, Nohara R, Itoh H: Safety and implementation of exercise testing and training after coronary senting in patients with acute myocardial infarction. Circulation J. 66(10)930-936.
  55. Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, Niimi A, Hattori N, Nohara R, Sasayama S, Nakao K, Mishima M, Nakamura T, Ohi M: Plasma leptin levels and cardiac sympathetic function in patiens with obstructive sleep apnoea hypopnoea syndrome. Thorax. 57(5)429-434.
  56. Sirakawa K, Muso E, Nogaki F, Maeda M, Kawamura T, Ono T, Yoshimoto M, Uno K, Kishida T, Sasayama S: Correlation between the severity of clinicopathological parameters and whole blood interferon-α production capacity in active phase IgA nephropathy patients. Nephron. 90 (1)24-30.
  57. Ono T, Liu N, Kusano H, Nogaki F, Makino T, Muso E, Sasayama S: Broad antiproliferative effects of benidipine on cultured human mesangial cells in cell-cycle phases. Am. J. Nephrol. 22: 581-586
  58. Makino T, Honda G, Ono T, Muso E: Effect of Perilla frutescens on production of nitric oxide and DNA synthesis of murine cultured vascular smooth muscle cell. Phytother. Res. 16 (Suppl. 1)19-23.
  59. Matsushima H, Yoshida H, Machiguchi T, Muso E, Matsuyama E, Tamura T, Sasayama S: Urinary albumin and TGF-β1 lavels as renal damage indices in patients with congestive heart failure. Clin. Exp. Nephrol. 6: 21-29
  60. Makino T, Ono T, Liu N, Nakamura T, Muso E, Honda G: Suppressive effects of rosmarinic acid on mesangial proliferative glomerulonephritis in rats. Nephron. 92 (4)898-904.
  61. Machiguchi T, Tei M, Ono T, Kambara H: Re-biopsy in a patient with IgA nephropathy showing success of treatment with cyclosporin A and angiotensin-II receptor blocker. Clin. Exp. Nephrol. 6: 166-169.
  62. Kusano H, Muso E, Ono T, Nogaki F, Nomura K, Takeda T, Miyawaki S, Matsumori A, Yoshida H, Sasayama S: Heminephrectomy causes the progression of glomerulosclerosis and apoptosis in high IgA strain ddY mice. Nephrology (suppl)A4.
  63. Oida E, NogakiI F, Kobayashi I, Kamata T, Ono T, Honjo T, Miyawaki S, Yoshida H, Muso E: Genetic analysis in a high IgA strain of ddY (HIGH)mice. Nephrology (suppl)A97
  64. Kobayashi I, Nogaki F, Kusano H, Ono T, Miyawaki S, Yoshida H, Muso E: Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol. Dial. Transpl. 17 (12)2108-2116.
  65. Yashiro M, Hamada Y, Matsushima H, Muso E: Estimation of filtration coefficients and circulating plasma volume by continuously monitoring hematocrit during hemodialysis. Blood Purif. 20: 569-576.
  66. Yuan Z, Kishimoto C, Shioji K, Nakamura H, Yodoi J, Sasayama S: Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression. Cardiovasc. Res. 55: 320-328
  67. Shioji K, Kishimoto C, Nakamura H, Masutani H, Yuan Z, Yodoi J: Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 106: 1403-1409
  68. Kishimoto C, Kurokawa M, Ochiai H: Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Moll. Cell. Cardiol. 34: 1227-1238.
  69. Kishimoto C, Shioji K, Ito H, Kinoshita M, Lee DJ, Shimizu H, Ueda T: Evaluation of arteriolar hyalinosis of the skin of patients with chronic congestive heart failure. Circulation J. 66: 382-384.
  70. Shioji K, Matsuura Y, Iwase T, Kitaguchi S, Nakamura H, Yodoi J, Hashimoto T, Kawai C, Kishimoto C: Successful immunoglobulin treatment for fulminant myocarditis with analysis of serum thioredoxin (TRX) A case report, Circulation J. 66: 977-980
  71. Sakai S, Ochiai H, Kishimoto C, Terasawa K: The possibility for the anti-chemokine therapy, especially focusing on macrophage inflammatory protein-2. Recent Devel. Antiviral. Res. 1, 59-62
  72. Hiraoka Y, Kishimoto C, Takada H, Ochiai H: Oral administration of L-arginine prevents congestive heart failure in murine viral myocarditis. J. Cardiovasc. Pharmacol. 40:1-8.
  73. Takada H, Kishimoto C, Hiraoka Y, Ochiai H: Oral L-arginine prevents murine coxsackievirus B3 myocarditis. Int. J. Cardiol. 86: 273-279.
  74. Takimoto Y, Aoyama T, Tanaka K, Keyamura R, Yui Y, and Sasayama S: Augmented protein expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats, Circulation 105: 490-496.
  75. Shimokawa H, Hiramori K, Hosoda S, Kishida H, Osada H, Katagiri T, Yamanouchi Y, Yui Y, Minamino T, Nakashima N and Kato K: Anti-anginal effect of Fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study, Journal of Cardiovasc. Pharmacol. Vol.40, P.751-761.
  76. Kinugawa T, Ogino K, Osaki S, Kato M, Endo A, Igawa O, Hisatome I, Fujita M, Shigemasa C: Prognostic significance of exercise plasma noradrenaline levels for cardiac death in patients with mild heart failure. Circulation J. 66:261-266.
  77. Tambara K, Fujita M, Nagaya N, Miyamoto S, Iwakura A, Doi K, Sakaguchi G, Nishimura K, Kangawa K, Komeda M: Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling. Heart 87:242-246.
  78. Fujita M, Miyamoto S, Tambara K, Budgell B: Trepopnea in patients with chronic heart failure. Int. J. Cardiol. 84: 115-118.
  79. Kinugawa T, Fujita M, Lee JD, Nakajima H, Hanada H, Miyamoto S: Effectiveness of a novel serotonin blocker, sarpogrelate, for patients with angina pectoris. Am. Heart J. 144: e1.
  80. Fujita M: FGF in pericardial fluid in unstable angina. In fibroblast growth factor in the cardiovascular system, ed. by Cuevas P. I. Holzapfel Publishers, Munich, 231-235.